Article
Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results.
Journal of clinical microbiology - 1 Jul 2007
Stevens Matthew P, Garland Suzanne M, Rudland Elice, Tan Jeffrey, Quinn Michael A, Tabrizi Sepehr N
Abstract excerpt
The development of cervical cancer is strongly associated with the presence of persistent high-risk (HR) human papillomavirus (HPV) infection. Recently, the commercially manufactured PCR-based Roche AMPLICOR (AMP) and LINEAR ARRAY (LA) HPV tests have become available for HPV detection. However, knowledge of their clinical performance compared to the U.S. Food and Drug Administration-approved Hybrid Capture 2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.